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Abstract: Micronutrient malnutrition affects billions of people world-wide, causing serious 
health problems. Different micronutrient interventions are currently being used, but their 
overall coverage is relatively limited. Biofortification – that is, breeding staple food crops for 
higher micronutrient contents – has been proposed as a new agriculture-based approach. Yet, 
as biofortified crops are still under development, relatively little is known about their 
economic impacts and wider ramifications. In this article, the main factors that will influence 
their future success are discussed, and a methodology for economic impact assessment is 
presented, combining agricultural, nutrition, and health aspects. Ex ante studies from India 
and other developing countries suggest that biofortified crops can reduce the problem of 
micronutrient malnutrition in a cost-effective way, when they are targeted to specific 
situations. Projected social returns on research investments are high and competitive with 
productivity-enhancing agricultural technologies. These promising results notwithstanding, 
biofortification should be seen as a complement rather than a substitute for existing 
micronutrient interventions, since the magnitude and complexity of the problem necessitate a 
multiplicity of approaches. Further research is needed to corroborate these findings and to 
address certain issues still unresolved at this stage. 
JEL classifications: I1, I3, O1, O3, Q1. 
Keywords: micronutrient malnutrition, public health, biofortification, agricultural 
technology, impact analysis, developing countries. 
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Micronutrient malnutrition is a widespread problem in many developing countries. An 
estimated four billion people are iron deficient, 2.7 billion are at risk of zinc deficiency, and 
hundreds of millions lack one or more essential vitamins (WHO, 2002; Hotz and Brown, 
2004; UN-SCN, 2004). The prevalence is especially high among the poor, whose diets are 
usually predominated by relatively cheap staple foods, with insufficient quantities of higher-
value nutritious foods. Micronutrient deficiencies are often the cause for increased mortality 
and morbidity, so that the resulting health burden can be immense. This health burden also 
entails significant economic costs in the developing world (Horton and Ross, 2003; FAO, 
2004). Accordingly, controlling micronutrient malnutrition has been ranked as a top 
development priority by eminent international economists (Lomborg, 2004). Economic 
growth and poverty reduction will help reduce the problem in the long run. Yet there are also 
more targeted micronutrient interventions being implemented, including food 
supplementation, industrial fortification, and nutrition education programs (Allen, 2003; 
World Bank, 1994). Recently, an agriculture-based approach has been proposed as a 
supplementary strategy, namely breeding staple food crops for higher micronutrient contents. 
This breeding approach has been termed ‘biofortification’ (Nestel et al., 2006). The potential 
positive effects of biofortification are obvious: if micronutrient-dense staple crops are widely 
grown and consumed by the poor, their nutritional status would improve, which could lead to 
significant health advantages and economic benefits. However, although plant breeders are 
working on the development of biofortified crop varieties, hardly any of these varieties has 
yet been released, so that the actual impacts are still uncertain. 
In this article, we analyze the implications of biofortification from an economic 
perspective. In the next section, we provide some more background about the problem of 
micronutrient malnutrition, before describing the biofortification approach in greater detail 
and discussing important factors that will influence its future success. A methodological 
  1framework for assessing the impacts of biofortification is set out in section 4. This 
methodology has been used for different empirical studies, results of which are presented in 
section 5. The last section concludes and discusses research and policy implications. 
 
2  Micronutrient malnutrition 
For a long time, the food security debate had primarily focused on undernutrition in terms of 
calories. Calorie undernutrition is usually the result of an insufficient intake of macronutrients 
(carbohydrates, protein, and fat) and is associated with a feeling of hunger. Hunger is still a 
serious problem in large parts of the developing world. According to the FAO, 852 million 
people worldwide were undersupplied with calories in 2002 (FAO, 2004). Micronutrient 
malnutrition is often less obvious for the people affected, which is also why the term ‘hidden 
hunger’ is sometimes used. For certain micronutrients, deficiencies are even more widespread 
than calorie undernutrition (Figure 1). The major reason for the high prevalence of 
insufficient micronutrient intakes is the lack of dietary diversity among the poor. Typical diets 
in low-income households are dominated by staple foods, which are a cheap source of calories 
but only provide little amounts of vitamins and minerals. In addition to income constraints, 
lack of awareness and cultural factors also often limit the consumption of more nutritious 
foods, even where these are available and accessible. Women and children are the most 
vulnerable groups: pregnancies, breast-feeding, and menstruation as well as rapid body 
growth in children increase micronutrient requirements and make it even more difficult to 
achieve adequate intakes (WHO, 2002). 
Here should appear Figure 1. 
Even though deficient people are often not aware of their inadequate nutritional status, 
micronutrient malnutrition can have severe health consequences, including increased 
susceptibility to infectious diseases, physical and mental impairments, and increased mortality 
  2rates (Micronutrient Initiative, 2004). Apart from seriously affecting the well-being of the 
people directly concerned, micronutrient malnutrition negatively impacts on aggregate 
productivity and economic development (World Bank, 1994; Horton and Ross, 2003). Hence, 
efforts to control the problem are justified on humanitarian as well as efficiency grounds. 
Several interventions are available to control micronutrient malnutrition. Common 
interventions include food supplementation, such as distributing vitamin capsules at regular 
intervals, and industrial fortification, that is, adding micronutrients to foodstuffs during 
processing. While existing micronutrient interventions have their particular strengths, they 
also have their weaknesses (Allen, 2003). For instance, large-scale distribution programs are 
resource-intensive, as they require continuous funding, infrastructure, trained personnel, 
reliable supplies, and monitoring. Moreover, information, education, and communication 
programs are necessary to ensure participation by the target groups. For industrial 
fortification, the main problem is reaching those in need, because the poor and malnourished 
often consume home-produced foods and only little amounts of processed products. 
Furthermore, fortified foods are often somewhat more expensive than their non-fortified 
counterparts, unless fortification is mandatory, which then, however, requires monitoring 
efforts to ensure compliance by food processors. While dietary diversification is considered 
the most sustainable approach to control micronutrient malnutrition, necessary behavior 
changes and income constraints are limiting factors in the short and medium run. In this 
context, the novel approach of biofortification may be a useful intervention to complement the 
existing set of strategies. 
 
3  The biofortification approach 
3.1  Ongoing research programs 
For a long time, no particular role was seen for agricultural technology in the fight against 
  3micronutrient malnutrition; grain micronutrient content was simply not an important selection 
criterion for plant breeders. This has changed more recently, when nutritional quality started 
to receive higher priority and breeders realized that increased micronutrient densities are not 
only compatible with superior agronomic traits, but may, in some cases, even enhance yields. 
Plant varieties that are more efficient in the uptake of trace minerals like iron and zinc can be 
higher yielding in low-quality soils, because these trace minerals are also required for plant 
vigor and growth (Welch, 2002; Graham et al., 1999). 
  A number of research and development (R&D) programs with the objective to increase 
micronutrient densities in staple food crops through breeding have been launched in recent 
years. The term ‘biofortification’ has been coined by the HarvestPlus Challenge Program of 
the Consultative Group on International Agricultural Research (CGIAR). This program 
concentrates on increasing iron, zinc, and beta-carotene (provitamin A) contents in six staple 
crop species, namely rice, wheat, maize, cassava, sweetpotato, and beans, and supports 
exploratory research in an additional ten crops. At this stage, research under HarvestPlus 
builds primarily on conventional breeding techniques, exploiting the variability of 
micronutrient contents found in available germplasm. 
However, conventional techniques cannot be used when the micronutrient of interest is 
absent from a particular crop. A case in point is rice, which produces beta-carotene in leaves 
and in tiny amounts also in rice husks, but not in the endosperm. Hence, in the Golden Rice 
project, transgenic techniques have been used to introduce the beta-carotene biosynthetic 
pathway into the endosperm of grain (Ye et al., 2000; Paine et al., 2005). The Golden Rice 
project involves European research organizations, the International Rice Research Institute 
(IRRI), and local partners in developing countries. Another crop-specific project (funded as 
part of the Global Grand Challenges in Health Initiative) is the Africa Biofortified Sorghum 
(ABS) Project, which seeks to develop a more nutritious and easily digestible sorghum that 
contains increased levels of beta-carotene, vitamin E, iron, zinc, and several amino acids. 
  4Furthermore, research has been conducted to genetically engineer iron-rich rice (Goto et al., 
1999; Lucca et al., 2001; Murray-Kolb et al., 2002), rice that is rich both in iron and zinc 
(Vasconcelos et al., 2003), iron-rich maize (Drakakaki et al., 2005), and beta-carotene-rich 
potato (Ducreux et al., 2005). While this is not a complete list of all related research 
initiatives, the portfolio is indicative of the attention that biofortification is likely to receive in 
the future food and nutrition security debate. 
 
3.2  Potential advantages 
The major expected and intended impact of biofortification is to increase micronutrient 
intakes among the poor, thus improving their nutrition and health status. By focusing breeding 
efforts on staple crops, which are consumed by the poor in larger quantities, the approach is 
self-targeting. Tying micronutrients to staple crops also reduces people’s nutritional 
vulnerability, because, when economic shocks occur, the poor tend to reduce their 
consumption of higher-value food commodities that are naturally rich in micronutrients. 
Furthermore, biofortification could be more sustainable than alternative micronutrient 
interventions. With a one-time R&D investment, biofortified germplasm can be shared 
internationally, and the varieties could spread through existing seed distribution systems. 
Since biofortified seeds can easily be reproduced, poor farmers in remote rural areas, with 
limited access to formal seed markets, could also be reached. Thus, unlike other micronutrient 
interventions, which require large funds on an annual basis, biofortification could produce a 
continuous stream of benefits with minimal recurrent costs. 
Biofortification promises to be a pro-poor and pro-rural approach, which could 
complement existing interventions. However, biofortified crops are still at the stage of R&D, 
so that these potential advantages have not yet materialized. The only exception are beta-
carotene-rich, orange-fleshed sweetpotatoes, which have been promoted in different countries 
(e.g., Low et al., 1997). 
  53.3  Factors influencing future impacts 
Whether biofortified crops will really contribute to an improved nutrition and health situation 
in developing countries will primarily depend on their efficacy and coverage in particular 
situations (Figure 2). Efficacy will be determined by the amount of the micronutrient in the 
crop, micronutrient retention after processing, and its bioavailability. Coverage, in turn, is 
mainly a function of farmer adoption and consumer acceptance of biofortified varieties. 
Here should appear Figure 2. 
Micronutrient content. Many varieties of staple food crops already contain certain 
amounts of micronutrients. For instance, high-yielding wheat varieties contain about 38 parts 
per million (ppm) of iron and 31 ppm of zinc. Popular rice varieties contain 3 ppm of iron and 
13 ppm of zinc in the milled grain. The potential to further increase these micronutrient 
contents by conventional breeding exists. Adequate genetic variations in concentrations of 
beta-carotene, other carotenoids, iron, zinc, and other minerals has been identified among 
cultivars, making selection of nutritionally appropriate breeding materials possible. For 
example, available orange-fleshed sweetpotato varieties contain over 100 µg/g of beta-
carotene. Nevertheless, with conventional breeding, achievable micronutrient contents are 
limited by the available genetic variation within each crop species. Transgenic techniques can 
help to further increase these levels, or to introduce micronutrients not naturally occurring in 
the crop. A case in point is Golden Rice: biotechnologists managed to produce a transgenic 
rice line containing up to 31 µg/g of beta-carotene in the endosperm (Paine et al., 2005). 
Where exactly the micronutrient is located within the grain matters considerably. If it is found 
mainly in the aleurone layer of the grain, the nutritional impact can be small, since the outer 
layers are removed during the process of milling and polishing; the impact is greater when it 
is located in the endosperm. Micronutrient toxicities are not expected at levels achieved 
through biofortification. For beta-carotene, toxicity is not an issue at all, because the human 
body only absorbs as much beta-carotene as it needs. 
  6Micronutrient retention. Micronutrient contents in the food actually consumed might be 
lower than those produced in the crop, because post-harvest and processing losses can occur. 
Beta-carotene in particular is sensitive to bright sunlight and extreme heat. For orange-fleshed 
sweetpotatoes, beta-carotene retention after boiling is around 80% (Nestel et al., 2006), but 
losses can be much higher with inappropriate storage and cooking techniques. Also for 
minerals, losses can occur, although they are usually less sensitive than vitamins and 
carotenoids. 
Bioavailability. How much of particular micronutrients the human body can absorb and 
use for body functions depends on a number of factors. The exact chemical composition of 
the micronutrient matters and also how the compound is stored within the plant cell. 
Furthermore, enhancing and inhibiting factors in people’s diets can have an important 
influence. Beta-carotene absorption, for instance, depends on minimum fat intakes, while 
alcohol reduces bioavailability. Iron bioavailability is positively influenced by vitamin C 
intake, but phytates and tannins act as inhibiting factors. Haas et al. (2005) have shown that 
high-iron rice can indeed improve the iron status of women. Similarly, van Jaarsveld et al. 
(2005) have shown that the consumption of orange-fleshed sweetpotato improves the vitamin 
A status of children: with 100 µg/g of beta-carotene and 80% retention when consumed in 
boiled form, even a 50 gram consumption of this crop is sufficient for meeting 75% of the 
recommended daily allowance of vitamin A for children. Also for Golden Rice, a relatively 
high bioavailability of the beta-carotene produced has been demonstrated in preliminary 
feeding trials (R. Russell, personal communication). While further research is needed to verify 
these findings in community settings, preliminary results from the dissemination of orange-
fleshed sweetpotato in Mozambique are suggestive of substantial nutritional impacts among 
micronutrient-deficient target populations. 
Farmer adoption. In order for farmers to adopt biofortified crops, micronutrient traits 
have to be bred into advanced lines, which are agronomically superior. Nutritional 
  7improvement at the cost of lower yields or other agronomic disadvantages is a non-starter. For 
example, wheat breeders are attempting to biofortify varieties resistant to a rust that is 
expected to affect large areas in Pakistan and India. Thus, adoption of biofortified wheat there 
is expected to be driven by rust resistance. It is rather unlikely that farmers are willing to pay 
higher prices for biofortified seeds, unless these seeds directly contribute to higher incomes. 
Also critical is local adaptation: varieties will have to be targeted to specific agroecological 
and socioeconomic conditions. The greater the number of locally-adapted biofortified 
varieties, the higher the likely adoption. For wide coverage, plant breeders will need to focus 
first on biofortifying ‘mega’ varieties, such as BR28 and BR29 of rice in Bangladesh, which 
together occupy almost 60% of the rice area in the Boro season, or BR11, which accounts for 
over a quarter of the Aman season rice area (IRRI, personal communication). Finally, the 
speed of adoption will depend on the efficiency of existing seed distribution channels and 
farmers’ seed replacement rates. Although biofortified seeds can be reproduced on-farm, 
some initial public support might be needed for the new varieties to penetrate formal and 
informal seed markets. 
Consumer acceptance. For reasons outlined earlier, awareness of micronutrient 
deficiencies is generally low, so that the nutritional advantages of biofortification might not 
be fully appreciated. But even if they are, the willingness and ability to pay higher prices for 
biofortified foods are likely to be limited among the poor, who bear the brunt of micronutrient 
malnutrition. Also at equal prices, consumers will only purchase micronutrient-dense crops, if 
they meet their personal preferences in terms of taste, texture, and visual appearance. Mineral 
biofortification at realistic levels is not expected to change consumer characteristics, that is, 
iron and zinc traits are invisible (Nestel et al., 2006). This is different for beta-carotene, which 
changes the color of the crop to deep yellow or orange, so that it will be necessary to invest 
more in demand creation for these varieties through communication and marketing efforts. 
  8Consumer acceptance also influences farmer adoption decisions, as low acceptance would 
translate into lower market prices. 
 
4  Methodology for impact assessment 
In agricultural economics, the usual approach to assess the impact of new crop technologies is 
to quantify the economic benefits arising from productivity increases as a result of technology 
adoption by farmers. Such productivity increases – either through yield gains or savings in 
production costs – cause a downward shift in the crop supply curve, based on which aggregate 
economic surplus and surplus distribution effects can be derived (Alston et al., 1995). 
However, the main focus of biofortification is on improving the nutritional status of 
consumers through quality enhancement. Quality improvements generally lead to a marginal 
benefit increase for consumers, which different authors have modeled as an upward shift in 
the crop’s demand function (e.g. Unnevehr, 1986). Yet it is unlikely that biofortification 
would result in an upward shift in demand, because of awareness and purchasing power 
constraints among the poor, as discussed above. In this case, benefits of biofortification 
should rather be considered as positive nutrition and health outcomes for individuals suffering 
from micronutrient malnutrition and related externalities for society at large. Such 
externalities are more complex to evaluate. 
  Dawe et al. (2002) looked at the potential nutritional effects of Golden Rice by 
analyzing likely improvements in vitamin A intakes in the Philippines. This approach 
implicitly builds on a measure of program success, which is commonly used also for other 
micronutrient interventions, namely the achieved reduction in the number of people with 
micronutrient intakes below a defined threshold (e.g. Fiedler et al., 2000). However, since 
micronutrient intake is not an end in itself but only a means to ensure healthy body functions, 
it is more appropriate to go further and quantify health outcomes directly. In a preliminary 
  9assessment of iron biofortification in India and Bangladesh, Bouis (2002) estimated the 
reduction in the number of anemia cases and attributed a monetary value to each case averted 
for a cost-benefit analysis. Zimmermann and Qaim (2004) suggested a more comprehensive 
approach in their analysis of the potential health benefits of Golden Rice in the Philippines: 
since micronutrient malnutrition causes significant health costs, which could be reduced 
through biofortification, they quantified the health cost of vitamin A deficiency with and 
without Golden Rice and interpreted the difference – that is, the health cost saved – as the 
technological benefit. 
 
4.1  Quantification of health costs 
There are different methodologies available for the quantification of health costs, including 
budgeting medical treatment costs, estimating productivity losses, and willingness to pay 
approaches (e.g., Brent, 2003). A framework which appears appropriate to quantify the health 
costs of micronutrient malnutrition in developing countries is the disability-adjusted life years 
(DALYs) approach. DALYs are used to establish the burden of a disease by measuring the 
health loss through mortality and morbidity in a single index (Murray and Lopez, 1996). The 
annual health costs of a disease are expressed in terms of the number of DALYs lost: 
(1)    Health costs = DALYs lost = YLL + YLD weighted
where  YLL are years of life lost due to premature deaths and YLD are years lived with 
disabilities resulting from the disease, which are weighted according to the severity of 
disabling conditions. 
The DALYs approach has been used in very different contexts, such as quantifying the 
health costs of malaria or HIV/AIDS (e.g., Lomborg, 2004). The World Health Organization 
has used it to assess the global health costs of different risk factors, including undernutrition 
and micronutrient malnutrition (WHO, 2002). In their Golden Rice study, Zimmermann and 
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adverse health outcomes of vitamin A deficiency. Stein et al. (2005) have further developed 
the approach by incorporating new nutrition insights and extending it also to iron and zinc 
malnutrition. For each micronutrient, the number of DALYs lost can be calculated as: 
(2)  
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where Tj is the total number of people in target group j, and Mj is the mortality rate associated 
with the particular deficiency. Iij is the incidence rate of adverse health outcome i in target 
group j, Dij is the corresponding disability weight, and dij is the duration of the outcome. For 
permanent health problems, dij equals the average remaining life expectancy Lj. Future life 
years lost are discounted at a discount rate of r. An overview of adverse health outcomes of 
iron, zinc, and vitamin A deficiency is shown in Table 1. Only those outcomes for which a 
definite causal relationship has been established in meta-analyses are included (Stein et al., 
2005a). 
Here should appear Table 1. 
Inserting appropriate health and demographic statistics in equation (2), the health costs of 
micronutrient malnutrition in a country or region can be calculated. Since biofortified crops 
are not yet consumed, this status quo situation is the benchmark without biofortification. 
Improved micronutrient intakes through consumption of biofortified crops will reduce 
mortality and incidence rates of adverse functional outcomes, so that the number of DALYs 
lost decreases.
1 The difference in micronutrient-related health costs – that is, the number of 
DALYs saved – is considered as the benefit of biofortification. 
 
                                                 
1 How the reduction in mortality and incidence rates can be derived is explained in the next sub-section. 
  114.2  Improved nutrition and health status through biofortification 
Micronutrient intakes required for healthy body functions vary from individual to individual, 
based on age, sex, physical activity, and many other factors. Recommended dietary reference 
intake levels for each micronutrient are usually specified for particular target groups. If the 
actual intake of an individual is below the recommended one, the person is likely to be 
deficient. An illustrative distribution of micronutrient intakes is shown in panel (a) of Figure 
3. In this example, a certain fraction of the population is deficient at current intake levels 
without biofortification. 
Here should appear Figure 3. 
Future consumption of biofortified crops will shift the intake distribution to the right, 
whereby the magnitude of the shift will depend on the actual improvement in bioavailable 
micronutrients, which is a function of efficacy and coverage, as discussed above. Some 
individuals, who were deficient previously, will achieve sufficiency status; for them, possible 
adverse health outcomes will cease. However, especially individuals at the lower end of the 
intake distribution might still remain deficient, even after the shift. Also for these individuals 
there will be an improvement in health status, though, because the prevalence and severity of 
adverse health outcomes is correlated with the degree of micronutrient deficiency. In fact, a 
convex relationship between micronutrient intake and adverse health outcomes can be 
assumed (Hallberg et al., 2000; Zimmermann and Qaim, 2004), as shown in panel (b) of 
Figure 3. The effectiveness of biofortification in improving health status can then be 
calculated as the ratio of the areas A and (A + B). The mean effectiveness for a particular 
target group (Ej) can be used to derive new, reduced incidence rates of adverse health 
outcomes as  ( ) ij j
new
ij I E I ⋅ − = 1 . For the reduction in mortality rates, the same formula can be 
used.
2
                                                 
2 While the approach described here can be used for all micronutrients, Stein et al. (2005a) proposed an 
  124.3  Cost-effectiveness and returns on R&D investments 
A comprehensive economic analysis of projects or policies requires that aggregate benefits 
are juxtaposed with aggregate costs. The major cost of biofortification is the investment in 
breeding and disseminating micronutrient-dense varieties. If the discounted biofortification 
investments are divided by the discounted number of DALYs saved, the average cost per 
DALY saved can be calculated, which is a common measure for the cost-effectiveness of 
health programs (e.g., World Bank, 1993). Based on this per-DALY cost, it is possible to 
compare the cost-effectiveness of biofortification with that of alternative micronutrient 
interventions, other public health measures, or pre-defined thresholds for what is considered 
cost-effective. 
One of the advantages of the DALYs approach is actually that health and life do not have 
to be expressed in monetary terms, since this is always associated with ethical concerns. Yet, 
since biofortification is an agricultural technology, which also competes with non-health 
related, productivity-enhancing technologies in terms of funding, a comparison of the returns 
on R&D investments might be desirable in some cases. This requires that a monetary value be 
attributed to each DALY saved, in order to convert the health benefits into a dollar figure. 
What value to choose per DALY saved is not a straightforward decision. In developing 
country contexts, a standardized rate of $1000 has sometimes been used (e.g., World Bank, 
1994). Other authors have valued DALYs at the average per-capita income in a country (e.g., 
Zimmermann and Qaim, 2004). These are certainly lower-bound values, and they should not 
be considered as an approach to quantify the intrinsic value of life. But, since higher values 
translate into larger monetary benefits, the results are more cautious and convincing if 
favorable returns can already be shown at these lower-bound values. 
 
                                                                                                                                                          
alternative method for iron, which derives the reduction in the prevalence of adverse health outcomes through 
biofortification by using the cumulative distribution function of iron intakes in a population. Where data 
availability permits, this alternative method is preferable for iron, but it is not suitable for zinc and vitamin A. 
  135  Empirical analyses 
5.1  Biofortification in India 
Using the methodology outlined in the previous section, first comprehensive studies on the 
impacts of biofortification have been carried for in India (Stein et al., 2005b; 2006a; 2006b), 
where micronutrient malnutrition is a widespread problem. About half of all women in India 
and three quarters of all children are anemic (IIPS, 2000),
3 the risk of zinc deficiency is high 
(Hotz and Brown, 2004), and almost one-third of all preschool children are vitamin A 
deficient (UN-SCN, 2004). In the framework of the HarvestPlus Challenge Program, crop 
scientists at IRRI and CIMMYT are using conventional tools to breed higher amounts of iron 
and zinc into rice and wheat. The resulting breeding lines will be shared with the Indian 
public research system for backcrossing the micronutrient traits into local varieties. In 
addition, transgenic Golden Rice breeding lines, with high amounts of beta-carotene, will be 
transferred to India through the Golden Rice Humanitarian Board. Adaptive research, testing, 
and deregulating the technologies will still take some time; it is expected that the first 
biofortified varieties might be released in India in 2010. Both rice and wheat are important 
staple foods in India, so that significant positive nutrition and health benefits can be expected 
in the future. 
Since much of the information needed for impact assessment is not observable at this 
stage, assumptions have to be made for ex ante analyses. Based on expert interviews, two 
impact scenarios were constructed – one with optimistic and the other one with more 
pessimistic assumptions. The major assumptions made on technology efficacy and coverage 
are shown in Table 2. Furthermore, estimated financial costs are shown. These costs include 
only part of the international R&D investments, because the biofortified breeding lines will be 
                                                 
3 Iron deficiency anemia is only a subgroup of anemia. But, because it is the most important form, anemia is 
often used as proxy for iron deficiency. It should be noted, however, that individuals can also suffer from iron 
deficiency without being anemic (Nestel and Davidsson, 2002). 
  14shared also with other developing countries. In addition, national program costs for adaptive 
breeding, testing, and dissemination have been considered. For Golden Rice, the aggregate 
costs are higher than for iron and zinc biofortification for two reasons. First, since Golden 
Rice is a transgenic technology, more costly biosafety and food safety tests have to be carried 
out under the national regulatory requirements. Second, since the beta-carotene turns the color 
of the rice grain yellow, public marketing efforts will be necessary to promote farmer and 
consumer acceptance. More intensive marketing efforts are expected to increase technology 
coverage. Since the projected marketing expenditures account for a large part of the total cost, 
the cost estimates for Golden Rice are higher in the optimistic than in the pessimistic scenario. 
Here should appear Table 2. 
Based on recent health and demographic statistics, the current health costs of 
micronutrient malnutrition in India were calculated. This was done separately for the three 
micronutrients iron, zinc, and vitamin A. The results are shown in Table 3. With an annual 
loss of 4 million DALYs, the aggregate costs of iron deficiency are higher than those of zinc 
and vitamin A deficiency. Although the latter two are associated with higher mortality, 
especially among children, they are less widespread than iron deficiency. For an ad-hoc 
estimate of the total health costs of all three micronutrient deficiencies together, the individual 
results can be added up, resulting in an annual loss of over 9 million DALYs. This indicates 
that hidden hunger is indeed a huge public health problem in India. The DALYs sum will 
underestimate the true costs, however, because – owing to micronutrient interactions – 
multiple deficiencies in individuals can lead to additional adverse health outcomes, which are 
not captured here. Only recently have nutritionists started to pay more attention to 
micronutrient interactions. At this stage, the knowledge available is not sufficient to 
incorporate these interactions into economic analyses. This is also the reason why iron, zinc, 
and provitamin A biofortification have been analyzed separately, although all three 
micronutrients might eventually be bred into the same crop varieties. 
  15Here should appear Table 3. 
For the impact analyses, a nationally representative data set was used, which includes 
detailed food consumption data for 120,000 Indian households (NSSO, 2001). Using local 
food composition tables and consumer equivalence units, the consumption of different food 
commodities was translated into micronutrient intakes for individuals. The results on health 
cost reductions through biofortification for the two impact scenarios are shown in the lower 
part of Table 3. Under optimistic assumptions, biofortified rice and wheat varieties could 
more than halve the health costs associated with micronutrient malnutrition in India. Even 
under pessimistic assumptions, the reduction is still significant, ranging between 9-19%. 
These findings suggest that biofortification is an effective way to reduce hidden hunger, albeit 
it is unlikely to eliminate the problem completely. The differences in impacts between the two 
scenarios are mainly due to the underlying assumptions on micronutrient contents in the grain 
and coverage rates of biofortified varieties. Since these parameters can still be influenced 
through appropriate policies, the results also demonstrate that public support is important for 
increasing the positive impacts. 
Results of cost-effectiveness analyses for the individual technologies are also shown in 
Table 3. The cost per DALY saved through biofortification is very low. The World Bank 
(1993) classifies health interventions as cost-effective, when the cost of saving one DALY is 
lower than US$ 200.
4 Thus, biofortification is highly cost-effective, even under pessimistic 
assumptions. Also, the cost-effectiveness of biofortification compares favorably with other 
micronutrient interventions. For instance, the cost per DALY saved through iron 
supplementation and industrial fortification efforts ranges between US$ 5.6-16.3 (Gillespie, 
1998). For zinc supplementation and fortification programs, it ranges between US$ 5.0-18.0, 
and for vitamin A interventions between US$ 84-599 (Tan-Torres Edejer et al., 2005). The 
                                                 
4 The World Bank (1993) gives a threshold of US$ 150 (in 1990 dollars); in current terms this corresponds to 
more than US$ 200. 
  16major reasons for the high cost-effectiveness of biofortification are the enormous health gains 
it generates and the low recurrent cost that accrues once micronutrient-dense varieties have 
been developed and fed into existing seed distribution systems.
5 This was discussed in greater 
detail in section 3. 
Additionally, internal rates of return (IRRs) for R&D investments in biofortification have 
been calculated using the lower-bound monetary values mentioned above for valuing each 
DALY saved, namely the international standard of US$ 1000 and the average Indian per-
capita income of US$ 620. Under optimistic assumptions in particular, IRRs are very high 
(Table 3). Even under pessimistic assumptions, they are still comparable to the average 
returns on R&D investments in productivity-enhancing agricultural technologies (Alston et 
al., 2000). These are clear indications that biofortification can be a worthwhile investment 
from a social point of view. 
 
5.2  Overview of other studies 
Further ex ante studies on the impacts of biofortification have been carried out at different 
CGIAR centers for HarvestPlus target crops and countries. These studies were mainly 
conducted for research priority setting within the HarvestPlus Challenge Program. The 
methodological approach in these additional studies was largely the same as the one outlined 
here, although data constraints necessitated the use of average food consumption data instead 
of individual household observations. Therefore, projections of nutritional improvements are 
based on mean values for the individual target groups rather than the entire sample 
distribution of micronutrient intakes. Additional details on assumptions are provided in 
Meenakshi et al. (2006). Results in terms of health benefits and cost-effectiveness are shown 
in Table 4 for selected crops and countries. All the examples shown are based on 
                                                 
5 Of course, where seed distribution systems are dysfunctional, coverage rates of biofortification will be lower or 
dissemination costs will be higher, both of which would result in a less favorable cost-effectiveness. 
  17micronutrient amounts that breeders reckon they can achieve using conventional breeding 
techniques. 
Here should appear Table 4. 
These additional results confirm that biofortification can reduce the problem of 
micronutrient malnutrition in developing countries. Most of the examples also suggest that 
biofortification is a cost-effective approach, certainly in Asia and Africa, and also in certain 
contexts in Latin America. However, there are also striking differences between the individual 
results. Comparison of the studies for rice in Bangladesh and the Philippines, for instance, 
demonstrates the influence of local dietary patterns. While rice is the main food staple for the 
poor in Bangladesh, average rice quantities consumed in the Philippines are lower, because 
maize is also an important staple in certain parts of the country. Similarly, cassava is only one 
staple crop among other important ones for poor households in the Northeast of Brazil. More 
detailed assessments on appropriate approaches have to be case-specific. It is clear, however, 
that there is no single crop or technique that will work in every situation. Indeed, in certain 
situations, biofortification may not enjoy a cost advantage over other interventions. 
 
6  Conclusions and research challenges ahead 
Micronutrient malnutrition is a widespread problem in developing countries, especially 
among women and children in the poorer segments of the population. The social costs 
associated with adverse health outcomes are often sizeable. Biofortification is a new, 
agriculture-based intervention, which is likely to gain in importance in the future, as indicated 
by the large number of related international research programs recently launched. As 
biofortified crops are still under development, relatively little is known about their economic 
impacts and wider ramifications. In this article, we have discussed the main factors that will 
influence their future success and have illustrated a suitable methodology for economic 
  18impact assessment, which combines agricultural, nutrition, and health aspects. Ex ante studies 
from India and other developing countries suggest that biofortified crops can reduce the 
problem of micronutrient malnutrition in a cost-effective way, when they are targeted to 
specific situations. 
The approach presented here is only a first step to explicitly consider nutrition and health 
aspects in impact assessments of agricultural technology. More basic research could help to 
further improve and extend the methodology and develop welfare measures which include 
health and quality of life components. Moreover, additional empirical work is required to 
verify the preliminary results reported here, including ex post studies building on observable 
data once biofortified crops are disseminated. In the case of the deployment of orange-fleshed 
sweetpotato, HarvestPlus researchers are planning a randomized evaluation of impact, an 
approach not commonly used in agricultural economics. Such ex post analysis will pose new 
challenges, especially with respect to indicators of success, as impact on crop adoption, food 
and micronutrient intakes, and nutritional outcomes have rarely been assessed under a 
unifying paradigm. This interdisciplinary research – involving economists, other social 
scientists, agronomists, and nutritionists – is critical for a more comprehensive analysis of the 
multiplicity of impacts of biofortification. 
Apart from impact analyses, there are also other open issues, which require further 
research. These include questions of bioavailability and micronutrient interactions in the 
human body. For instance, enhanced iron and zinc content go hand-in-hand for several crops, 
and their combined impact may be greater than what a single nutrient alone may achieve. 
Similarly, nutrient interactions are important in understanding the impact of biofortifying 
multiple crops. In many countries, diets often feature a primary and one or more secondary 
staple crops – cassava is commonly eaten with beans in many parts of Africa and Latin 
America, for example. The higher beta-carotene content of cassava may enhance the 
absorption of the iron in beans. Likewise, nutrient interactions in plants and linkages between 
  19high micronutrient concentrations and other crop characteristics are not yet fully understood. 
And finally, it is still unclear how stable the micronutrient traits will be when seeds are 
repeatedly reproduced by farmers. A rapid trait dilution would certainly put the assumed 
sustainability of the biofortification approach into question. 
Where there are technical constraints in breeding, transgenic approaches could help to 
increase the amounts beyond what is possible through conventional breeding alone. 
Transgenic approaches are also needed when a particular micronutrient does not occur 
naturally in a crop. Cases in point are the lack of beta-carotene in the endosperm of rice and 
wheat. While transgenic approaches may further increase the impact of biofortification, they 
may also involve additional complications in terms of regulatory requirements and consumer 
acceptance. 
In spite of further research challenges ahead, an important policy implication, which 
already emerges from the evidence so far, is that biofortification can play an important role in 
achieving nutrition security in particular situations. Apart from the high expected cost-
effectiveness, preliminary cost-benefit analyses show that social returns on R&D investments 
into biofortification are favorable and highly competitive with productivity-enhancing 
agricultural technologies. Therefore, further pursuing the strategy of biofortification appears 
to be worthwhile. Related funding will have to come primarily from the public sector or 
humanitarian organizations. Although the projected social benefits are sizeable, neither 
farmers nor poor consumers are likely to have a higher willingness to pay for biofortified 
crops, so that incentives for the private sector to invest are rather limited. 
To conclude, biofortification should not be seen as substitute for existing micronutrient 
interventions but as a complementary strategy. No single approach will eliminate the problem 
of micronutrient malnutrition, as our results also indicate. All interventions have their 
strengths and weaknesses in particular situations. While supplementation and industrial 
fortification might be more suitable for urban areas and feeding programs for well defined 
  20target groups, biofortification is likely to achieve a wider coverage, including in remote rural 
areas, which are often underserved by other interventions. It is only in the long run that 
poverty reduction and economic growth may be expected to contribute to dietary 
diversification; in the interim, other interventions need to be implemented. 
 
Acknowledgements 
The financial support of the German Research Foundation (DFG) is gratefully acknowledged. 
We thank Penelope Nestel, H.P.S. Sachdev, and Zulfiqar A. Bhutta, who cooperated with us 
in this research and provided invaluable inputs on nutritional details. 
 
References 
Allen, L.H., 2003. Interventions for Micronutrient Deficiency Control in Developing 
Countries: Past, Present and Future. Journal of Nutrition 133, 3875S-3878S. 
Alston, J.M., C. Chan-Kang, M.C. Marra, P.G. Pardey, and T.J. Wyatt, 2000. A Meta-
Analysis of Rates of Return to Agricultural R&D – Ex Pede Herculem? IFPRI Research 
Report 113, International Food Policy Research Institute, Washington, DC. 
Alston, J.M., G.W. Norton, and P.G. Pardey, 1995. Science Under Scarcity: Principles and 
Practice for Agricultural Research Evaluation and Priority Setting. Cornell University 
Press, Ithaca. 
Bouis, H.E., 2002. Plant Breeding: a New Tool for Fighting Micronutrient Malnutrition. 
Journal of Nutrition 132, 491S-494S. 
Brent, R.J., 2003. Cost-Benefit Analysis and Health Care Evaluations. Edward Elgar, 
Cheltenham. 
Dawe, D., R. Robertson, and L. Unnevehr, 2002. Golden Rice: What Role Could it Play in 
Alleviation of Vitamin A Deficiency? Food Policy 27, 541-560. 
Drakakaki, G., S. Marcel, R.P. Glahn, E.K. Lund, S. Pariagh, R. Fischer, P. Christou, and E. 
Stoger, 2005. Endosperm-Specific Co-Expression of Recombinant Soybean Ferritin and 
Aspergillus Phytase in Maize Results in Significant Increases in the Levels of Bioavailable 
Iron. Plant Molecular Biology 59, 869-880. 
  21Ducreux, L.J.M., W.L. Morris, P.E. Hedley, T. Shepherd, H.V. Davies, S. Millam, and M.A. 
Taylor, 2005. Metabolic Engineering of High Carotenoid Potato Tubers Containing 
Enhanced Levels of β-Carotene and Lutein. Journal of Experimental Botany 56, 81-89. 
FAO, 2004. The State of Food Insecurity in the World 2004. Food and Agriculture 
Organization of the United Nations, Rome. 
Fiedler, J.L., D. Dado, H. Maglalang, N.R. Juban, M. Capistrano, and M.V. Magpantay, 2000. 
Cost Analysis as a Vitamin A Program Design and Evaluation Tool: A Case Study of the 
Philippines. Social Science & Medicine 51, 223-242. 
Gillespie, S., 1998. Major Issues in the Control of Iron Deficiency. Micronutrient Initiative, 
Ottawa. 
Goto, F., T. Yoshihara, N. Shigemoto S. Toki, and F. Takaiwa, 1999. Iron Fortification of 
Rice Seed by Soybean Ferritin Gene. Nature Biotechnology 17, 282-286. 
Graham, R.D., D. Senadhira, S.E. Beebe, C. Iglesias, and I. Ortiz-Monasterio, 1999. Breeding 
for Micronutrient Density in Edible Portions of Staple Food Crops: Conventional 
Approaches. Field Crop Research 60, 57-80. 
Hallberg, L., L. Hulthén, and L. Garby, 2000. Iron Stores and Hemoglobin Iron Deficits in 
Menstruating Women; Calculations Based on Variations in Iron Requirements and 
Bioavailability of Dietary Iron. European Journal of Clinical Nutrition 54, 650-657. 
Haas, J.D., J.L. Beard, L.E. Murray-Kolb, A.M. del Mundo, A. Felix, and G.B. Gregorio, 
2005. Iron-Biofortified Rice Improves the Iron Stores of Nonanemic Filipino Women. 
Journal of Nutrition 135, 2823-2830. 
Horton, S. and J. Ross, 2003. The Economics of Iron Deficiency. Food Policy 28, 51-75. 
Hotz, C. and K.H. Brown (Eds.), 2004. Assessment of the Risk of Zinc Deficiency in 
Populations and Options for its Control. International Zinc Nutrition Consultative Group 
Technical Document No. 1, Food and Nutrition Bulletin 25, S91-S204. 
IIPS, 2000. National Family Health Survey (NFHS-2), 1998-99: India. International Institute 
for Population Sciences, Mumbai. 
Lomborg, B. (Ed.), 2004. Global Crises, Global Solutions. Cambridge University Press, 
Cambridge. 
Low, J., P. Kinyae, S. Gichuki, M.A. Oyunga, V. Hagenimana, and J. Kabira, 1997. 
Combating Vitamin A Deficiency through the Use of Sweetpotato. International Potato 
Center, Lima. 
  22Lucca, P., R. Hurrell, and I. Potrykus, 2001. Genetic Engineering Approaches to Improve the 
Bioavailability and the Level of Iron in Rice Grains. Theoretical and Applied Genetics 
102, 392-397. 
Meenakshi, J.V. N. Johnson, V.M. Manyong, H. De Groote, D. Yanggen, J. Javelosa, F. 
Naher, C. Gonzalez, J. Garcia, and E. Meng, 2006. Analysing the Cost-Effectiveness of 
Biofortification: A Synthesis of the Evidence. Paper presented at the Annual AAEA 
Meeting, July 23-26, Long Beach, CA. 
Micronutrient Initiative, 2004. Vitamin & Mineral Deficiency: A Global Progress Report. 
Micronutrient Initiative, Ottawa and UNICEF, New York. 
Murray, C.J.L. and A.D. Lopez (Eds.), 1996. The Global Burden of Disease; Vol. I and II. 
Harvard University Press, Cambridge, MA. 
Murray-Kolb, L.E., F. Takaiwa, F. Goto, T. Yoshihara, E.C. Theil, and J.L. Beard, 2002. 
Transgenic Rice Is a Source of Iron for Iron-Depleted Rats. Journal of Nutrition 132, 
957-960. 
Nestel, P. and L. Davidsson, 2002. Anemia, Iron Deficiency, and Iron Deficiency Anemia. 
International Nutritional Anemia Consultative Group (INACG), Washington, DC. 
Nestel P., H.E. Bouis, J.V. Meenakshi, and W. Pfeiffer, 2006. Biofortification of Staple Food 
Crops. Journal of Nutrition 136, 1064-1067. 
NSSO, 2001. Level and Pattern of Consumer Expenditure in India 1999-2000, NSS 55th 
Round, Report No. 457. National Sample Survey Organization, New Delhi. 
Paine, J.A., C.A. Shipton, S. Chaggar, R.M. Howells, H.J. Kennedy, G. Vernon, S.Y. Wright, 
E. Hinchliffe, J.L. Adams, A.L. Silverstone, and R. Drake, 2005. Improving the Nutritional 
Value of Golden Rice Through Increased Pro-vitamin A Content. Nature Biotechnology 
23, 482-487. 
Stein, A.J., J.V. Meenakshi, M. Qaim, P. Nestel, H.P.S. Sachdev, and Z.A. Bhutta, 2005a. 
Analyzing the Health Benefits of Biofortified Staple Crops by Means of the Disability-
Adjusted Life Years Approach: A Handbook Focusing on Iron, Zinc and Vitamin A. 
HarvestPlus Technical Monograph  4, International Food Policy Research Institute, 
Washington, DC and International Center for Tropical Agriculture, Cali. 
Stein A.J., J.V. Meenakshi, M. Qaim, P. Nestel, H.P.S. Sachdev, and Z.A. Bhutta, 2005b. 
Health Benefits of Biofortification: An Ex-Ante Analysis of Iron-Rich Rice and Wheat in 
India. Paper presented at the AAEA Annual Meeting, July 24-27, Providence, RI. 
  23Stein, A.J., P. Nestel, J.V. Meenakshi, M. Qaim, H.P.S. Sachdev, and Z.A. Bhutta, 2006a. 
Plant Breeding to Control Zinc Deficiency in India: How Cost-Effective is 
Biofortification? Public Health Nutrition, forthcoming. 
Stein, A.J., H.P.S. Sachdev, and M. Qaim, 2006b. Potential Impacts of Golden Rice on Public 
Health in India. Paper presented at the 26
th IAAE Conference, August 12-18, Broadbeach. 
Tan-Torres Edejer, T., M. Aikins, R. Black, L. Wolfson, R. Hutubessy, and D.B. Evans, 2005. 
Cost Effectiveness Analysis of Strategies for Child Health in Developing Countries. British 
Medical Journal 331, e1177. 
UN-SCN, 2004. 5
th Report on the World Nutrition Situation. United Nations, Standing 
Committee on Nutrition, Geneva. 
Unnevehr, L.J., 1986. Consumer Demand for Rice Grain Quality and Returns to Research for 
Quality Improvement in Southeast Asia. American Journal of Agricultural Economics 68, 
634-641. 
van Jaarsveld, P.J., M. Faber, S.A. Tanumihardjo, P. Nestel, C.J. Lomrad, and A.J.S. Benadé, 
2005. β-Carotene-Rich Orange Fleshed Sweetpotato Improves the Vitamin A Status of 
Primary School Children Assessed by the Modified-Relative-Dose-Response Test. 
American Journal of Clinical Nutrition 81, 1080-1087. 
Vasconcelos, M., K. Datta, N. Oliva, M. Khalekuzzaman, L. Torrizo, S. Krishnan, M. 
Oliveira, F. Goto, and S.K. Datta, 2003. Enhanced Iron and Zinc Accumulation in 
Transgenic Rice with the Ferritin Gene. Plant Science 164, 371-378. 
Welch, R. M., 2002. Breeding Strategies for Biofortified Staple Plant Foods to Reduce 
Micronutrient Malnutrition Globally. Journal of Nutrition 132, 495S-499S. 
WHO, 2002. The World Health Report 2002 – Reducing Risks, Promoting Healthy Life. 
World Health Organization, Geneva. 
World Bank, 1993. World Development Report 1993; Investing in Health. Oxford University 
Press, New York. 
World Bank, 1994. Enriching Lives: Overcoming Vitamin and Mineral Malnutrition in 
Developing Countries. Washington, DC, World Bank. 
Ye, X., S. Al-Babili, A. Klöti, J. Zhang, P. Lucca, P. Beyer, and I. Potrykus, 2000. 
Engineering the Provitamin A (β-Carotene) Biosynthetic Pathway into (Carotenoid-Free) 
Rice Endosperm. Science 287, 303-305. 
Zimmermann, R. and M. Qaim, 2004. Potential Health Benefits of Golden Rice: A Philippine 
Case Study. Food Policy 29, 147-168. 
  24Tables and figures 
 















Iron Zinc Iodine Calories Vitamin A
Sufficient Deficient
 
Sources: WHO (2002), Hotz and Brown (2004), UN-SCN (2004), FAO (2004). 
 
 
Figure 2. Factors influencing the impact of biofortified crops 













  25Figure 3. Improvement in micronutrient intakes and health outcomes through biofortification 


















































































































  26Table 1. Adverse health outcomes of micronutrient deficiencies for different target groups 
Target group  Iron deficiency  Zinc deficiency  Vitamin A deficiency 
Children  • Impaired physical 
activity 
• Impaired mental 
development 
• Child mortality (related 




• Child mortality 
• Child mortality 
• Measles 
• Night blindness 
• Corneal scarring 
• Blindness 
Women  • Impaired physical 
activity 
• Maternal mortality 
  • Night blindness in 
pregnant and lactating 
women 
Men  • Impaired physical 
activity 
  
Source: Stein et al. (2005a). 












Baseline MN content  3 ppm Fe 
a 38 ppm Fe 
b 13 ppm Zn 
a 31 ppm Zn 
b 0 µg/g βC 
a
  Optimistic scenario 
Improved MN content  8 ppm Fe 
a 61 ppm Fe 
b 35 ppm Zn 
a 68 ppm Zn 
b 31 µg/g βC 
a
MN  retention  100% 100% 100% 100%  65% 
Coverage  50% 50% 50% 50% 50% 
R&D cost (net present value)  US$ 3.6 m  US$ 4.5 m  US$ 3.6 m  US$ 4.5 m  US$ 27.9 m 
  Pessimistic scenario 
Improved MN content  6 ppm Fe 
a 46 ppm Fe 
b 20 ppm Zn 
a 37 ppm Zn 
b 14 µg/g βC 
a
MN  retention  100% 100% 100% 100%  20% 
Coverage  20% 30% 20% 30% 14% 
R&D cost (net present value)  US$ 12.6 m  US$ 13.8 m  US$ 12.6 m  US$ 13.8 m  US$ 21.4 m 
Notes: MN = micronutrient, ppm = parts per million, Fe = iron, Zn = zinc, µg = microgram, βC = beta-carotene. 
 
a Micronutrient contents shown are for milled rice. 
b Micronutrient contents shown are for whole grain.  
Sources: Stein et al. (2005b; 2006a; 2006b). 
 











Health cost of deficiency without 
biofortification (DALYs lost) 
4.0 m  2.8 m  2.3 m 
  Optimistic scenario 
DALYs saved through biofortification  2.3 m  1.6 m  1.4 m 
Reduction in health cost (%)  58  55  59 
Cost per DALY saved (US$/DALY)   0.46  0.68  3.06 
IRR (%, DALY valued at US$ 620)  149  135  70 
IRR (%, DALY valued at US$ 1000)  168  153  77 
  Pessimistic scenario 
DALYs saved through biofortification  0.8 m  0.5 m  0.2 m 
Reduction in health cost (%)  19  16  9 
Cost per DALY saved (US$/DALY)   5.39  8.80  19.40 
IRR (%, DALY valued at US$ 620)  53  46  31 
IRR (%, DALY valued at US$ 1000)  61  53  35 
Notes: 
a Iron biofortification of rice and wheat is considered. 
b Zinc biofortification of rice and wheat is 
considered. 
c Biofortification of rice with beta-carotene is considered (Golden Rice). 
Sources: Stein et al. (2005b; 2006a; 2006b). 
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  Reduction in health cost (%)    Cost per DALY saved (US$) 
  Optimistic Pessimistic    Optimistic Pessimistic 
  Iron 
Rice,  Bangladesh  21  8  3  10 
Rice, Philippines  11  4    49  197 
Beans, Northeast Brazil  36  9    13  56 
Beans, Honduras  22  4    20  114 
  Zinc 
Rice, Bangladesh  46  15    2  6 
Rice, Philippines  39  11    7  46 
Beans, Northeast Brazil  20  5    95  799 
Beans, Honduras  15  3    48  423 
  Provitamin A 
Sweetpotato, Uganda  64  38    4  10 
Maize, Kenya  32  8    10  44 
Cassava,  Nigeria  28  3  3  35 
Cassava, Northeast Brazil  19  4    84  434 
Source: Meenakshi et al. (2006). 
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